Kadıyoran, C. (2025) “Syndecan-1 as a Biomarker for Cardiovascular Risk in Patients with Behçet’s Disease”, Archives of Rheumatology, 40(4), pp. 435–442. doi: 10.5152/ArchRheumatol.2025.11178.